How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease

被引:145
作者
Prabu-Jeyabalan, M [1 ]
Nalivaika, E [1 ]
Schiffer, CA [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Toxicol, Worcester, MA 01655 USA
关键词
HIV-1; protease; homodimer; substrate specificity; crystallography; molecular recognition;
D O I
10.1006/jmbi.2000.4018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of an actual HIV-1 protease-substrate complex is presented at 2.0 Angstrom resolution (X-value of 19.7% (R-free 23.3%)) between an inactive variant (D25N) of HIV-1 protease and a long substrate peptide, Lys-Ala-Arg-Val-Leu-Ala-Glu-Ala-Met-Ser, which covers a full binding epitope of capsid(CA)-p2 cleavage site. The substrate peptide is asymmetric in both size and charge distribution. To accommodate this asymmetry the two protease monomers adopt different conformations burying a total of 1038 Angstrom(2) Of surface area at the protease-substrate interface. The specificity for the CA-p2 substrate peptide is mainly hydrophobic, as most of the hydrogen bonds are made with the backbone of the peptide substrate. Two water molecules bridge the two monomers through the loops Gly49-Gly52 (Gly49'-Cly52') and Pro79'-Val82' (Pro79-Val82). When other complexes are compared, the mobility of these loops is correlated with the content of the P1 and P1' sites. Interdependence of the conformational changes allows the protease to exhibit its wide range of substrate specificity. (C) 2000 Academic Press.
引用
收藏
页码:1207 / 1220
页数:14
相关论文
共 48 条
[1]   INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRICAL PHOSPHINATE - SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS [J].
ABDELMEGUID, SS ;
ZHAO, BG ;
MURTHY, KHM ;
WINBORNE, E ;
CHOI, JK ;
DESJARLAIS, RL ;
MINNICH, MD ;
CULP, JS ;
DEBOUCK, C ;
TOMASZEK, TA ;
MEEK, TD ;
DREYER, GB .
BIOCHEMISTRY, 1993, 32 (31) :7972-7980
[2]   TRANSDOMINANT INHIBITORY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE MONOMERS PREVENT PROTEASE ACTIVATION AND VIRION MATURATION [J].
BABE, LM ;
ROSE, J ;
CRAIK, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10069-10073
[3]   STRUCTURE OF HIV-1 PROTEASE WITH KNI-272, A TIGHT-BINDING TRANSITION-STATE ANALOG CONTAINING ALLOPHENYLNORSTATINE [J].
BALDWIN, ET ;
BHAT, TN ;
GULNIK, S ;
LIU, BS ;
TOPOL, IA ;
KISO, Y ;
MIMOTO, T ;
MITSUYA, H ;
ERICKSON, JW .
STRUCTURE, 1995, 3 (06) :581-590
[4]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[5]   CRYSTAL-STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEINASE COMPLEXED WITH AND INHIBITOR [J].
BHAT, TN ;
BALDWIN, ET ;
LIU, BS ;
CHENG, YSE ;
ERICKSON, JW .
NATURE STRUCTURAL BIOLOGY, 1994, 1 (08) :552-556
[6]   FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES [J].
BRUNGER, AT .
NATURE, 1992, 355 (6359) :472-475
[7]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[8]  
Chou KC, 1996, PROTEINS, V24, P51, DOI 10.1002/(SICI)1097-0134(199601)24:1&lt
[9]  
51::AID-PROT4&gt
[10]  
3.0.CO